[HTML][HTML] Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations

MV Bennett, K McLaurin, C Ambrose, HC Lee�- PLoS One, 2018 - journals.plos.org
Objective Respiratory syncytial virus (RSV) is a common pathogen during infancy, with the
potential to cause serious disease and mortality in high-risk groups. The objective of this�…

[HTML][HTML] Trends in respiratory syncytial virus and bronchiolitis hospitalization rates in high-risk infants in a United States nationally representative database, 1997�…

A Doucette, X Jiang, J Fryzek, J Coalson, K McLaurin…�- PLoS�…, 2016 - journals.plos.org
Background Respiratory syncytial virus (RSV) causes significant pediatric morbidity and is
the most common cause of bronchiolitis. Bronchiolitis hospitalizations declined among US�…

Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study

JP Fryzek, WJ Martone, JR Groothuis�- Advances in Therapy, 2011 - Springer
Introduction Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infections in infants and young children and the leading cause of hospitalization in infants�…

Respiratory syncytial virus–associated hospitalizations among children less than 24 months of age

CB Hall, GA Weinberg, AK Blumkin, KM Edwards…�- …, 2013 - publications.aap.org
BACKGROUND: Respiratory syncytial virus (RSV) infection is a leading cause of
hospitalization among infants. However, estimates of the RSV hospitalization burden have�…

Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years

W Na'amnih, E Kassem, S Tannous, V Kagan…�- Epidemiology &�…, 2022 - cambridge.org
The study aim was to examine the incidence and risk factors of respiratory syncytial virus
(RSV) bronchiolitis hospitalisations and disease severity among infants. We compared�…

Effectiveness of respiratory syncytial virus immunoprophylaxis in reducing bronchiolitis hospitalizations among high-risk infants

P Wu, GJ Escobar, T Gebretsadik…�- American Journal of�…, 2018 - academic.oup.com
We sought to determine the real-world effectiveness of respiratory syncytial virus (RSV)
immunoprophylaxis in a population-based cohort to inform policy. The study population�…

[HTML][HTML] Chronologic age at hospitalization for respiratory syncytial virus among preterm and term infants in the United States

RC Parikh, KK McLaurin, AV Margulis…�- Infectious Diseases and�…, 2017 - Springer
Introduction Respiratory syncytial virus (RSV) is the leading cause of hospitalization among
infants in the United States, and the risk for RSV hospitalizations is greater for infants born�…

Mortality associated with respiratory syncytial virus, bronchiolitis, and influenza among infants in the United States: a birth cohort study from 1999 to 2018

H Reichert, M Suh, X Jiang, N Movva…�- The Journal of�…, 2022 - academic.oup.com
Background Infant mortality due to respiratory syncytial virus (RSV) in the United States is
not well understood. Methods From 1999 to 2018, RSV, bronchiolitis, and influenza deaths�…

[HTML][HTML] Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants

KK McLaurin, AM Farr, SW Wade, DR Diakun…�- Journal of�…, 2016 - nature.com
Objective: Infection with respiratory syncytial virus (RSV), which causes lower respiratory
tract infections, is the leading cause of hospitalization among children< 1 year old in the�…

[HTML][HTML] Effects of chronologic age and young child exposure on respiratory syncytial virus disease among US preterm infants born at 32 to 35 weeks gestation

EAF Simoes, EJ Anderson, X Wu, CS Ambrose�- PLoS One, 2016 - journals.plos.org
Objective To estimate the incidence of respiratory syncytial virus (RSV) disease as a function
of chronologic age and exposure to young children in US preterm infants. Methods In the�…